Bispecific Antibodies in the Treatment of Multiple Myeloma

被引:0
|
作者
Zhou, Xiang [1 ]
Xiao, Xianghui [1 ]
Kortuem, Klaus Martin [1 ]
Einsele, Hermann [1 ,2 ]
机构
[1] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany
[2] Oberdurrbacher St 6, D-97080 Wurzburg, Germany
关键词
Multiple myeloma; Immunotherapy bispecific antibody; CAR T cell; CELL MATURATION ANTIGEN; BONE-MARROW; PRECLINICAL ACTIVITY; MONOCLONAL-ANTIBODY; PLUS LENALIDOMIDE; PLASMA-CELLS; THERAPY; TECLISTAMAB; ADHESION; TARGET;
D O I
10.1016/j.hoc.2023.12.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:361 / 381
页数:21
相关论文
共 50 条
  • [1] Bispecific Antibodies for the Treatment of Multiple Myeloma
    Scott R. Goldsmith
    Shawn Streeter
    Fahrettin Covut
    [J]. Current Hematologic Malignancy Reports, 2022, 17 : 286 - 297
  • [2] Bispecific Antibodies for the Treatment of Multiple Myeloma
    Goldsmith, Scott R.
    Streeter, Shawn
    Covut, Fahrettin
    [J]. CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2022, 17 (06) : 286 - 297
  • [3] Bispecific antibodies in the treatment of multiple myeloma
    Devasia, Anup Joseph
    Chari, Ajai
    Lancman, Guido
    [J]. BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [4] Bispecific antibodies in multiple myeloma
    Escure, Guillaume
    Manier, Salomon
    [J]. BULLETIN DU CANCER, 2021, 108 (10) : S205 - S212
  • [5] Bispecific Antibodies: A New Era of Treatment for Multiple Myeloma
    Zhou, Xiang
    Einsele, Hermann
    Danhof, Sophia
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07) : 1 - 14
  • [6] Bispecific antibodies in multiple myeloma treatment: A journey in progress
    Cho, Shih-Feng
    Yeh, Tsung-Jang
    Anderson, Kenneth C.
    Tai, Yu-Tzu
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [7] Bispecific Antibodies in Multiple Myeloma: Present and Future
    Lancman, Guido
    Sastow, Dahniel L.
    Cho, Hearn J.
    Jagannath, Sundar
    Madduri, Deepu
    Parekh, Samir S.
    Richard, Shambavi
    Richter, Joshua
    Sanchez, Larysa
    Chari, Ajai
    [J]. BLOOD CANCER DISCOVERY, 2021, 2 (05): : 423 - 433
  • [8] Bispecific antibodies for the treatment of relapsed/refractory multiple myeloma: updates and future perspectives
    Parrondo, Ricardo D.
    Ailawadhi, Sikander
    Cerchione, Claudio
    [J]. FRONTIERS IN ONCOLOGY, 2024, 14
  • [9] Bispecific Antibodies for the Management of Relapsed/Refractory Multiple Myeloma
    Tacchetti, Paola
    Barbato, Simona
    Mancuso, Katia
    Zamagni, Elena
    Cavo, Michele
    [J]. CANCERS, 2024, 16 (13)
  • [10] Current use of bispecific antibodies to treat multiple myeloma
    Lee, Holly
    Neri, Paola
    Bahlis, Nizar J.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2023, (01) : 332 - 339